AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

VGlip-M Tablet

Prescription Icon
Prescription Required

Marketer

Eurip life sciences

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview VGlip-M Tablet

Metformin and Vildagliptin, combined in VGlip-M tablets, effectively manage elevated blood glucose in patients with type 2 diabetes. This dual-action approach mitigates the risk of severe diabetic complications, including nephropathy and vision impairment, and may also lessen the likelihood of cardiovascular events. VGlip-M can be used as monotherapy or in conjunction with other antidiabetic agents. Optimal therapeutic response requires adherence to a healthy diet and regular physical activity. Dosage is individualized based on your health status, glycemic control, and concomitant medications. Consuming the tablet with food minimizes gastrointestinal discomfort. Consistent daily administration at the same time maximizes effectiveness; discontinuation should only occur under medical supervision. Maintaining blood sugar regulation prevents future complications. Continued adherence to your doctor's dietary and exercise plan is crucial for successful diabetes management; lifestyle modifications are paramount. Commonly reported adverse effects include diarrhea, nausea, vomiting, dyspepsia, cephalalgia, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential risk, especially when combined with insulin or sulfonylureas; learn to identify and manage this condition. This medication isn't suitable for all individuals. Consult your physician before commencing treatment if you have a history of renal, hepatic, or cardiac disease, pancreatic disorders, or significant alcohol consumption. Pregnant or lactating women require medical consultation. Inform your doctor of all medications you are taking to ensure compatibility and safety. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Your doctor will monitor renal function and blood glucose levels throughout your treatment.

Primary Ingredients of VGlip-M Tablet

The provided text is "undefined," so no rephrasing is possible.

Uses of VGlip-M Tablet

Managing Type 2 diabetes

Major Benefits of VGlip-M Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take VGlip-M Tablet with a meal.

Common Side effects of VGlip-M Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use VGlip-M Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; do not chew, crush, or divide it. VGlip-M Tablets should be administered with food.

How VGlip-M Tablet works:

Metformin and vildagliptin are combined in VGlip-M tablets to manage diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Avoid alcohol while taking VGlip-M Tablets.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using VGlip-M tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of VGlip-M Tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Individuals with impaired kidney function should use VGlip-M Tablets cautiously. Dosage modification of VGlip-M Tablets may be necessary. Physician consultation is advised.

LiverLiverUNSAFE

Patients with liver conditions should not take VGlip-M Tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take VGlip-M Tablet :

Should you forget a VGlip-M Tablet dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About VGlip-M Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Medication

FAQs on VGlip-M Tablet

VGlip-M Tablets rarely cause hypoglycemia by themselves; however, low blood sugar can result from inadequate caloric intake while using this medication. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness. These symptoms are more pronounced if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a quick-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of VGlip-M Tablets. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take other medications without your doctor's advice.
VGlip-M Tablets are contraindicated in patients allergic to any ingredient or excipient. This medication should also not be used by individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
VGlip-M tablets combine the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated in individuals under 18.
VGlip-M Tablet can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates avoiding VGlip-M in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue VGlip-M and seek immediate medical attention.
Prolonged VGlip-M Tablet use can lead to Vitamin B12 deficiency by impairing its absorption in the stomach. This deficiency, if left unaddressed, may result in anemia and neurological complications.
VGlip-M Tablets are safe when used as directed by your doctor. However, even with proper dosage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and low blood sugar (hypoglycemia, especially with insulin or sulfonylurea) may occur. Report any persistent issues to your physician.
VGlip-M Tablet
77
MRP 89
13% off